Breast Cancer
National Cancer Research Institute researcher presents way to predict response to anthracyclines
Published in Drug Week, January 19th, 2007
Women sometimes discontinue therapy, or avoid it altogether, because of anxiety about the effects of these drugs. Unfortunately, some patients will not respond to the drug, and will experience the often-devastating side effects in vain. Now a report from the 29th Annual San Antonio Breast Cancer Symposium suggests that there may be a straightforward way to predict who will respond to anthracycline drugs, based on a commonly measured tumor marker.
Multiple clinical trials...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-01-19)
More Articles from Drug Week
- Breast Cancer
Positive Herceptin data presented at San Antonio Breast Cancer Symposium - Dermatology
Plymouth Pharmaceuticals launches Eczemol for eczema - HIV/AIDS Therapy
Data from Gilead's study comparing Viread, Emtriva to Combivir published - Abscess Therapy
Reports from Hospital, Department of Internal Medicine advance knowledge in abscess therapy - Allergies
New allergy in children study findings have been reported from Washington University - Alzheimer Disease Therapy
New alzheimer disease therapy study findings have been reported by scientists at National Hospital for Neurology and Neurosurgery - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
